SE8303385L - 1,4-dihydropyridinderivat, i optisk aktiv form eller i racematform och deras framstellning samt farmaceutiska kompositioner - Google Patents

1,4-dihydropyridinderivat, i optisk aktiv form eller i racematform och deras framstellning samt farmaceutiska kompositioner

Info

Publication number
SE8303385L
SE8303385L SE8303385A SE8303385A SE8303385L SE 8303385 L SE8303385 L SE 8303385L SE 8303385 A SE8303385 A SE 8303385A SE 8303385 A SE8303385 A SE 8303385A SE 8303385 L SE8303385 L SE 8303385L
Authority
SE
Sweden
Prior art keywords
optically active
racemat
preparation
pharmaceutical compositions
compounds
Prior art date
Application number
SE8303385A
Other languages
English (en)
Swedish (sv)
Other versions
SE8303385D0 (sv
Inventor
A Vogel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8303385D0 publication Critical patent/SE8303385D0/xx
Publication of SE8303385L publication Critical patent/SE8303385L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8303385A 1982-06-15 1983-06-14 1,4-dihydropyridinderivat, i optisk aktiv form eller i racematform och deras framstellning samt farmaceutiska kompositioner SE8303385L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH369282 1982-06-15
CH369382 1982-06-15

Publications (2)

Publication Number Publication Date
SE8303385D0 SE8303385D0 (sv) 1983-06-14
SE8303385L true SE8303385L (sv) 1983-12-16

Family

ID=25693638

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303385A SE8303385L (sv) 1982-06-15 1983-06-14 1,4-dihydropyridinderivat, i optisk aktiv form eller i racematform och deras framstellning samt farmaceutiska kompositioner

Country Status (19)

Country Link
AU (1) AU1575383A (de)
BE (1) BE897000A (de)
CA (1) CA1208639A (de)
CH (1) CH660593A5 (de)
DE (1) DE3320616A1 (de)
DK (1) DK271183A (de)
ES (2) ES8504179A1 (de)
FI (1) FI832072A7 (de)
FR (1) FR2528431B1 (de)
GB (1) GB2122192B (de)
HU (1) HU191853B (de)
IT (1) IT1178353B (de)
NL (1) NL8302067A (de)
NZ (1) NZ204536A (de)
PH (1) PH23436A (de)
PT (1) PT76870B (de)
SE (1) SE8303385L (de)
WO (1) WO1984000033A1 (de)
ZA (1) ZA834409B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0353238A1 (de) * 1987-03-27 1990-02-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue zwischenprodukte und verfahren
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (zh) * 2005-12-31 2008-10-15 清华大学 一种有机电致发光材料及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Also Published As

Publication number Publication date
GB2122192A (en) 1984-01-11
CA1208639A (en) 1986-07-29
PT76870A (en) 1983-07-01
ES523243A0 (es) 1985-04-01
FR2528431A1 (fr) 1983-12-16
IT8348488A0 (it) 1983-06-13
SE8303385D0 (sv) 1983-06-14
AU1575383A (en) 1983-12-22
PH23436A (en) 1989-08-07
CH660593A5 (de) 1987-05-15
DE3320616A1 (de) 1983-12-15
FR2528431B1 (fr) 1986-01-10
NL8302067A (nl) 1984-01-02
WO1984000033A1 (fr) 1984-01-05
GB8316054D0 (en) 1983-07-20
DK271183A (da) 1983-12-16
NZ204536A (en) 1986-09-10
ZA834409B (en) 1985-02-27
FI832072L (fi) 1983-12-16
PT76870B (en) 1986-02-27
BE897000A (fr) 1983-12-09
GB2122192B (en) 1985-12-18
ES538157A0 (es) 1986-02-01
ES8504179A1 (es) 1985-04-01
FI832072A0 (fi) 1983-06-08
IT1178353B (it) 1987-09-09
FI832072A7 (fi) 1983-12-16
HU191853B (en) 1987-04-28
DK271183D0 (da) 1983-06-13
ES8604578A1 (es) 1986-02-01

Similar Documents

Publication Publication Date Title
NO173785C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk virksomme kinuklidinderivater samt mellom-produkt for fremstillingen
FI864614A0 (fi) Nya difosfonsyraderivat, foerfaranden foer framstaellning av dessa samt laekemedel innehaollande dessa foereningar.
DK164937C (da) Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden
NO883994D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer.
DK161146C (da) Analogifremgangsmaade til fremstilling af (2-halogenergolinyl)-n',n'-diethylurinstofderivater samt farmaceutisk acceptable syreadditionssalte heraf
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
SE8303385D0 (sv) 1,4-dihydropyridine derivatives, in optically active or in racemate form and their production and pharmaceutical compositions
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
ES2079469T3 (es) (pirrolidin-2-ona-l-il) acetamidas como mejoradores de aprendimiento y memoria y composiciones farmaceuticas que las comprenden.
SE8700015L (sv) Sett att framstella racemiska cis- och/eller trans-apovinkaminsyraestrar
PT90813A (pt) Processo de preparacao de derivados da fenotiazina e de composicoes farmaceuticas que os contem
SE8303719L (sv) Eburnan-oximderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
ZA88208B (en) Sweetening agents derived from guanidinoacetic and ethanamidinoacetic acids,process for sweetening various products,and compositions containing such sweetening agents
IL72647A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
ES479170A1 (es) Procedimiento de preparacion de un derivado esteroide-espiro-oxazolidinona.
DK149199C (da) Analogifremgangsmaade til fremstilling af hexahydro-1,4-oxazepiner eller salte deraf dannet med fysiologisk acceptable syrer
SE7908439L (sv) Nya beta-laktonderivat av 2-hydroxicyklopentankarboxylsyra, sett for framstellning och anvendning derav som lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
ATE15667T1 (de) Neue substituierte 3,5-diamino-1,2,4-oxadiazole und 3,5-diamino-1,2,4-thiadiazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
SE8803765D0 (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
ES435361A1 (es) Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos.
FI915980A0 (fi) Alkylaminoalkylamin- och eter- foereningar samt foerfaranden och mellanprodukter foer deras framstaellning och laekemedel som innehaoller dessa foereningar.
ATE19081T1 (de) Benzo-1,2-thiazin-1,1-dioxidderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8302452D0 (sv) Method for treatment of senile dementia
SE8303721L (sv) Nya eburnanoximeter derivat och forfarande for framstellning av dessa foreningar
ES2062469T3 (es) Derivados de amino-acidos sustituidos, procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8303385-2

Format of ref document f/p: F